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During vertebrate development, mesenchymal progenitors capable of forming bone, cartilage, muscle, fat, or tendon arise from either neural crest or
somitic mesoderm. Transcriptional programs that specify mesenchymal cell
fates are initiated and modified by paracrine cues provided by TGF-β superfamily members and mediated in part via the regulated assembly of Smadcontaining multiprotein transcription factor complexes. In this issue of the
JCI, Hoffmann and colleagues have identified that Smad8 activation drives
tendon formation from C3H10T1/2 cells, a murine cell line that recapitulates many features of normal multipotent mesenchymal cells (see the related article beginning on page 940). Cells programmed to the tenocyte cell fate
in vitro formed tenogenic grafts in vivo. These results add to the accumulating evidence that proliferating, multipotent mesenchymal progenitor cells
can be programmed to yield multiple cell types — e.g., osteoblasts, myocytes,
chondrocytes, and tenocytes — that may be useful in cell-based therapeutic
approaches to musculoskeletal diseases.
Tendon and ligament injuries represent
some of the most common musculoskeletal disorders that clinicians address daily,
ranging from as mundane as a mild ankle
sprain to the crippling effects of Achilles
tendon rupture or flexor tendon injury
in the hand (1). Severe tendon injuries
are difficult to manage. Surgical repairs
frequently do not fully restore function
due to fibrous adhesions or failure arising
from the mechanical demands placed on
Nonstandard abbreviations used: BMP, bone morphogenetic protein; GDF, growth differentiation factor;
L+MH2, R-Smad linker plus MH2 domain; R-Smad,
receptor-regulated Smad.
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imperfect integrative healing at tendontendon or tendon-bone interfaces (1).
The tendon itself is a dense, regular connective tissue consisting primarily of type
I collagen and the interspersed specialized
mesenchymal cells known as tenocytes
that are responsible for the maintenance
of collagen structure, with avascular
bundles of primary fibers invested by a
thin layer of endotenon, a fine loose connective tissue sheath, to form fascicles
(2) (Figure 1). Parallel arrays of fascicles
are bundled together to form tendon by
the epitenon, a layer contiguous with the
endotenon through which the microvasculature, lymphatics, and innervation
delicately traverses (2).
The ontogeny of the tenocyte lineage is
only beginning to be understood. Elegant
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work recently forthcoming from the Tabin
laboratory has demonstrated that during
embryogenesis, a unique compartment of
the somite called the syndetome provides
tenocyte progenitors (3). Inductive interactions between the well-described myotome
and sclerotome layers generate the syndetome, demarcated at the earliest stages of
development by expression of the basic
helix-loop-helix transcription factor gene
Scleraxis. In addition to promoting tenocyte “birth,” the myoprogenitors of the
myotome appear to prevent chondrogenic
differentiation of tenocyte progenitors.
The paracrine signals that fine-tune multipotent mesenchymal progenitors to the
unique tenocyte fate during normal development are virtually unknown, but appear
to involve FGFs (3) and key members of the
TGF-β superfamily such as growth differentiation factor 5 (GDF5) and GDF7 (4).
A tenogenic Smad
Thus, given our limited understanding of
how mesenchymal progenitors are efficiently recruited to the tenocyte lineage,
the recent progress made by Hoffmann
and colleagues in a report in this issue
of the JCI is quite remarkable (5). Their
insights into the mechanisms controlling
tenocyte differentiation arose from fortuitous observations made while studying
Smad signaling in C3H10T1/2 cells — a
murine multipotent mesenchymal cell line
that recapitulates many features of par-
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Figure 1
Organizational structure of tendon. Tendon is a nonmineralized, dense regular connective tissue that consists primarily of type I collagen. The
major executive cell type of tendon, the tenocyte, synthesizes and secretes trihelical tropocollagen that is assembled and cross-linked in parallel
fibrillar arrays. Higher-order organization of these arrays is provided by the endotenon, a loose connective tissue layer that envelopes collagen
fibrils to form tendon fascicles. Fascicles in turn are bundled together by the epitenon, a layer contiguous with the endotenon through which
the microvasculature traverses and provides nutrient supply (1, 2). Dependent upon anatomic venue, the tendon either may (e.g., hand flexor
tendon) or may not (e.g., Achilles tendon) be housed within a synovial sheath (1, 2).

axial mesenchymal progenitors and can
form osteoblasts, chondrocytes, adipocytes, or skeletal myocytes in culture (6, 7)
(Figure 2A). Smads are a group of related
intracellular proteins that transmit TGF-β
superfamily signals from ligand-activated cell surface receptors to the nucleus.
Smads are related to, but structurally distinct from, other intracellular effector proteins and are composed of 3 domains: an
N-terminal MH1 domain, a linker region,
and a C-terminal MH2 domain (Figure
2B). Receptor-regulated Smads (R-Smads)
associated with bone morphogenetic protein (BMP) signaling — Smad1, Smad5,
and Smad8 — were expressed as consti864

tutively active R-Smad linker plus MH2
domain (L+MH2) fragments lacking the
N-terminal MH1 regulatory domain (8),
and responses were assessed in the presence or absence of paracrine BMP2 signals (5). As previously shown (9), Smad1
and Smad5 directed alkaline phosphatase
induction characteristic of osteoblast
differentiation. By contrast, the Smad8
L+MH2 fragment markedly enhanced the
adoption of tenocyte-like cell morphology, suggesting tenocytic differentiation.
Consistent with this notion, the syndetome and tenocyte marker Scleraxis (3)
was induced by the BMP2/Smad8 L+MH2
combination along with other charac-
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teristic tenocyte genes such as Six1, Six2,
EphA4, and procollagen type I, a1 (Col1A1)
(5). The expression of most osteogenic
markers (e.g., parathyroid hormone/parathyroid hormone–related protein receptor
and alkaline phosphatase) was downregulated by the BMP2/Smad8 L+MH2 tenocytic trigger, although osteocalcin expression was not. Intriguingly BMP2, but not
TGF-β or GDF5, could provide paracrine
cues necessary for efficient tenocyte differentiation directed by Smad8 L+MH2.
Importantly, C3H10T1/2 cells engineered
to express both BMP2 and Smad8 L+MH2
provided gap replacement of tendon-like
tissue in a rat tenotomy model. Cells
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ectopic bone and cartilage foci within the
grafts, while Smad8 L+MH2 cells yielded
only unorganized loose connective tissue.
Immunohistochemistry to detect LacZ
expression following adenovirus tagging
and engraftment confirmed that the
engineered BMP2/Smad8 L+MH2 cells
did indeed contribute to the neotendon
formed in vivo. Thus, the authors demonstrate the formation of tendon-like neotendon efficiently in vivo by BMP2 and
Smad8 programming of mesenchymal
progenitor cells (5).

Figure 2
Lineage programming of mesenchymal progenitors: a working model. (A) During development,
mesenchymal progenitors capable of forming bone, cartilage, muscle, fat, or tendon arise from
either neural crest or from mesoderm. Transcriptional programs (shown in italics) that specify
mesenchymal cell fates are initiated and modified by paracrine cues provided by TGF-β superfamily members, mediated via regulated assembly of Smad-containing multiprotein transcription
factor complexes (8). During somitic mesoderm lamination, the syndetome — demarcated by
Scleraxis expression — forms at the interface between the bone-forming sclerotome and muscle-forming myotome to generate tenocytes of axial tendons (3). Similar mechanisms are likely
deployed during appendicular tendon formation. Not shown are the influences of paracrine Wnt
and FGF signaling cascades and homeodomain proteins of the Pax, Msx, Dlx, and Six families
that modulate BMP signaling. The data reported by Hoffmann et al. (5) indicate that activated
Smad8 promotes tenocyte differentiation of C3H10T1/2 cells. Whether Smad8 participates in
syndetome development is unknown. C/EBP, CCAAT/enhancer binding protein; MRF, muscle
regulatory factor; MRTF, myocardin-related transcription factor; SRF, serum response factor.
(B) R-Smad and L+MH2 structures. Although the MH1 domain encodes a DNA-binding function,
Smad interaction with other transcription factors is required for gene regulation; these interactions
are directed by the L+MH2 domain (8). The SxS motif is the cognate for phosphorylation-dependent Smad activation by activin-like kinase receptors. Smad4 and importins mediate nuclear
entry. Since the Smad8 L+MH2 fragment lacks intrinsic DNA binding, its tenogenic actions are
mediated by regulatory protein-protein interactions.

expressing BMP2, Smad8 L+MH2, or the
combination BMP2/Smad8 L+MH2 were
introduced to a surgical partial-thickness
Achilles tendon gap on an implantable
collagen matrix sponge. Using histology and micro-MRI to monitor collagen
fiber orientation and healing in vivo,
the authors documented neotendon

formation in implanted sponges carrying C3H10T1/2 cells programmed with
BMP2/Smad8 L+MH2. No ectopic endochondral bone formation occurred, and
laser capture microdissection and RTPCR confirmed murine Col1A1 expression. By contrast, C3H10T1/2 cells programmed with only BMP2 generated
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The combinatorial conundrum
Many questions remain to be answered
regarding the science of signal
transduction and the needs of musculoskeletal medicine. It is unclear why paracrine
BMP2 signaling is required to efficiently
elaborate the full tenogenic potential of a
constitutively active Smad8 L+MH2 fragment; it remains to be determined why
removal of the MH1 domain — although
capable of permitting Smad8 L+MH2
transactivation in transient transfection
assays — is insufficient to promote robust
tenogenesis in the absence of BMP2-generated signals. BMP2 receptor activation
may trigger the phosphorylation-dependent nuclear transport and coregulator
recruitment necessary for Smad8 tenogenic transcriptional complexes (8). While
BMP2 clearly alters the phosphorylation
of Smad8, it cannot activate full-length
Smad8 — i.e., the intact MH1+L+MH2
molecule (Figure 2B) (5). Other regulatory
receptor-ligand pairs presumably activate
Smad8 in native context, perhaps mediated by a GDF family member other than
GDF5 (4). GDF7 (also known as BMP12)
has recently been shown to drive rhesus
marrow mesenchymal cell differentiation to the tenocyte lineage in vitro (10).
Of note, neither GDF5 nor TGF-β1 were
capable of enhancing Smad8 phosphorylation (5). Whether Smad8 participates in
syndetome maturation and normal tendon development is as yet unknown. However, Smad8 signaling in mesenchymal
cells is clearly not osteogenic and clearly
drives gene expression programs different from those activated by Smad1 and
Smad5. Indeed, Smad8 inhibits Smad1
and Smad5 signaling recruited by BMP4
during ventral mesoderm induction (11).
While most artificially activated activinlike kinases can induce Smad8 phosphorylation, the “receptorology” of this R-Smad
in vivo has yet to be determined.
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A new opportunity
in regenerative medicine
Of note, BMP2 enhances collagen production by canine tenocytes (12) and has
been used to enhance tendon-bone integration in canine disease models (13). In
this robustly validated preclinical model,
surgical technique and postoperative
physical therapy can be used to assess
functional outcome and biomechanical
strength (1) — the hallmarks of tendon
repair that must be addressed in future
studies. Immunologic and vascularization
responses that influence the formation of
fibrous adhesions may also be augmented
by programmed neotendon cells and thus
hamper restoration of function (14). Given
that multipotent mesenchymal progenitors
resembling C3H10T1/2 cells can be isolated from tissues such as adipose (15) and
skeletal muscle (16), engineered autografts
might be best explored in canine models of
tendon injury repair to minimize the deleterious immune responses; such responses
may limit healing, biomechanical strength,
and restoration of function. Nevertheless,
the novel results reported here by Hoffmann et al. (5) add to the accumulating
evidence that proliferating, multipotent
mesenchymal progenitor cells can be programmed to yield yet another cell type

— the tenocyte — which may be potentially
useful in cell-based therapeutic approaches
to musculoskeletal injuries (1).
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A new cardiac MASTer switch
for the renin-angiotensin system
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The aspartyl protease renin was first isolated from the kidney by Tigerstedt
more than a century ago. In the kidney, renin secretion is tightly linked to
sodium intake and renal perfusion pressure, reflecting the important role
of the renin-angiotensin system (RAS) in controlling body fluid volume and
blood pressure. The study by Mackins et al. in this issue of the JCI describes
a novel source of renin: the mast cell (see the related article beginning on
page 1063). This discovery suggests a distinct pathway for activation of the
RAS that may have a particular impact on the pathogenesis of chronic tissue
injury as well as more acute pathology such as arrhythmias in the heart.
Nonstandard abbreviations used: ACE, angiotensinconverting enzyme; JG, juxtaglomerular; RAS, reninangiotensin system.
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Separate renin-angiotensin systems
in the circulation and in tissues
The renin-angiotensin system (RAS) is a hormone system in which the substrate protein
angiotensinogen is sequentially cleaved by
peptidases, renin and angiotensin-converting enzyme (ACE), to form the biologically
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active octapeptide angiotensin II (Figure
1). A substantial excess of angiotensinogen
is present in serum, and ACE is ubiquitous
in the endothelium and plasma (1). Accordingly, in the bloodstream, the amount of
renin is the rate-limiting step determining
the level of angiotensin II and thus the activity of the system.
The primary source of renin in the circulation is the kidney, where its expression and secretion are tightly regulated at
the juxtaglomerular (JG) apparatus by 2
distinct mechanisms: a renal baroreceptor
(2, 3) and sodium chloride delivery to the
macula densa (4, 5). Through these sensing mechanisms, levels of renin in plasma
can be incrementally titrated in response
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